Business Context and Reporting Period
This Form 8-K is filed by HEALTHEQUITY, INC. (NASDAQ: HQY) with a report date of May 5, 2026. The filing addresses Item 5.02(e) regarding amendments to employment agreements for key executives and changes to equity award vesting terms.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on executive compensation arrangements and does not contain financial performance data.
Material Changes
On May 5, 2026, the Company amended employment agreements for six executives, including CEO Scott Cutler and CFO James Lucania. The material changes include:
- Enhanced Severance for CEO: Scott Cutler's severance now includes 12 months of base salary plus his target cash bonus. If termination occurs within 18 months of a change in control, this increases to 18 months of base salary plus 150% of the target cash bonus.
- Enhanced Severance for Other Executives: For other named executives, severance includes 12 months of base salary plus the target cash bonus if termination occurs within 18 months of a change in control.
- Equity Vesting Acceleration: Effective March 25, 2026, new vesting terms were approved for equity awards granted after that date. Upon termination without cause or for good reason prior to a change in control:
- Time-based Restricted Stock Units (RSUs) scheduled to vest within 12 months of termination will fully vest immediately.
- Performance-based Restricted Stock Units (PSUs) will be prorated based on days employed and remain eligible to vest based on actual performance.
Guidance, Outlook, and Risks
The filing does not contain forward-looking guidance, management commentary on business outlook, or specific risk factors beyond the standard conditions for receiving severance (e.g., execution of a general release of claims). The full text of the amendments and award agreements will be filed in the next Quarterly Report on Form 10-Q.
Investor Verification Checklist
- Verify the specific definitions of "without cause" and "good reason" in the full employment agreements to understand the triggers for enhanced severance.
- Review the upcoming Form 10-Q for the complete text of the employment amendments and equity award agreements.
- Assess the potential financial impact of the enhanced severance and accelerated equity vesting on future compensation expenses, particularly in the event of a change in control.
- Confirm the exact number of RSUs and PSUs granted to executives after March 25, 2026, to quantify the potential acceleration liability.